Connect your AI

Evommune EVMN Common Stock Convertible Conversion Price Decrease

Common Stock Convertible Conversion Price Decrease at other companies

Evommune EVMN

$0.09—

Evommune EVMN

25%—

Evommune EVMN

$0.10—

Quantum Computing Inc.QUBT

$5.00—

Evommune EVMN

50%—

Corvex MOVE

$136,364.00—

Other financials

Income statement

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:CommonStockConvertibleConversionPriceDecrease.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's common stock convertible conversion price decrease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evommune 's common stock convertible conversion price decrease?: Evommune (EVMN) reported common stock convertible conversion price decrease of $0.09 in Q4 2025.
What does common stock convertible conversion price decrease mean?: Indicates a downward adjustment in the price at which convertible securities can be exchanged for common stock, often triggered by anti-dilution provisions or financing events. This metric is a key indicator of potential future dilution for existing shareholders.